文献速递妇科

糖尿病女性对妇科泌尿系统网片的炎症反应失调及其意义

Dysregulated inflammatory response to urogynecologic meshes in women with diabetes and its implications.
PubMed 文献 · Am J Obstet Gynecol · 2024-02-24

本研究回顾200例网片取出患者资料,其中25例糖尿病,发现糖尿病组网片植入后血糖控制不佳,取出组织存在持续慢性炎症,M2巨噬细胞和辅助T细胞标志物表达增加,促炎趋化因子Ccl24和Ccl13上调,而Il1a下调,凋亡细胞清除功能受损,提示糖尿病与网片植入后长期炎症反应改变相关。

要点

  • 糖尿病组网片取出组织中M2巨噬细胞标志物Mrc1和辅助T细胞标志物Cd4表达较非糖尿病组增加。
  • 糖尿病组促炎趋化因子Ccl24和Ccl13基因表达分别上调1.5倍和1.8倍,而Il1a下调2.2倍。
  • 糖尿病组凋亡细胞清除功能受损,CALR和AXL蛋白水平显著升高。

核心结论

  • 糖尿病与复杂网片植入后长期炎症反应改变相关,尤其涉及先天免疫细胞功能障碍。
  • 网片植入后血糖控制不佳可能促进这种免疫失调,需要进一步的机制研究。

研究设计与样本

  • 回顾性研究,纳入200例接受网片取出并参与网片生物样本库研究的患者,其中确诊糖尿病者25例。
  • 评估糖尿病患者初次网片植入前及网片取出前后的血糖和糖化血红蛋白水平。
  • 对年龄和体重指数匹配的糖尿病与非糖尿病患者的切除组织进行转录组分析、免疫荧光和蛋白检测。

主要发现

  • 糖尿病组体重指数较非糖尿病组高11.6%(P=.005),其余人口学和临床特征包括网片植入至取出时间、取出原因和网片类型等两组相当。
  • 糖尿病患者中59%在网片取出前后血糖控制不佳。
  • 糖尿病组较非糖尿病组M2巨噬细胞标志物Mrc1表达增加(P=.023),辅助T细胞标志物Cd4表达增加(P=.047)。
  • 糖尿病组较非糖尿病组促炎趋化因子Ccl24基因表达上调1.5倍(P=.035),Ccl13上调1.8倍(P=.027),而Il1a下调2.2倍(P=.037)。
  • 糖尿病组较非糖尿病组凋亡细胞表面「eat-me」信号CALR蛋白水平显著升高(P=.031),介导凋亡细胞清除的AXL蛋白水平也升高(P=.030)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Diabetes is an independent risk factor for mesh complications in women undergoing mesh-augmented surgical repairs of stress urinary incontinence and/or pelvic organ prolapse. The underlying mechanism remains unclear. OBJECTIVE: This study aimed to define the diabetes-associated alterations in the host inflammatory response to mesh and correlate them with perioperative glucose management. STUDY DESIGN: Deidentified demographics and medical records of patients who underwent mesh removal and participated in a mesh biorepository study were reviewed (n=200). In patients with diagnosed diabetes (n=25), blood glucose management before initial mesh implantation and before and after mesh removal was assessed by blood glucose and hemoglobin A1c levels. Age- and body mass index-matched tissue samples excised from patients with and without diabetes were examined. Transcriptomic profiles of immune cell markers, immune mediators, key inflammatory regulators, cell senescence, and epigenetic enzymes were determined by multiplex transcriptomic assays (NanoString). Ratios of apoptotic cells to CD68+ macrophages were examined with immunofluorescence. Protein profiles of 12 molecules involved in apoptotic cell clearance were examined with a multiplex protein assay (Luminex). RESULTS: Demographic and clinical characteristics, including duration between mesh implantation and removal, reason for removal, and type of mesh, etc., were comparable between patients with and without diabetes, except for 11.6% higher body mass index in the former (P=.005). In patients with diabetes, suboptimal management of blood glucose following mesh implantation was observed, with 59% of the patients having loosely or poorly controlled glucose before and after the mesh removal. Ongoing chronic inflammatory response was observed in the excised mesh-tissue complexes in both groups, whereas markers for M2 macrophages (Mrc1 [mannose receptor C-type 1]) and helper T cells (Cd4 [CD4 molecule]) were increasingly expressed in the diabetic vs nondiabetic group (P=.023 and .047, respectively). Furthermore, the gene expressions of proinflammatory Ccl24 (C-C motif chemokine ligand 24) and Ccl13 (C-C motif chemokine ligand 13) were upregulated by 1.5- and 1.8-fold (P=.035 and .027, respectively), whereas that of Il1a (interleukin 1 alpha) was paradoxically downregulated by 2.2-fold (P=.037) in the diabetic vs nondiabetic group. Interestingly, strong positive correlations were found between the expression of Ccl13, Setdb2 (SET domain bifurcated histone lysine methyltransferase 2), and M2 macrophage markers, and between the expression of Il1a, Fosl1 (activator protein-1 transcription factor subunit), and dendritic cell markers, suggesting the involvement of macrophages and dendritic cells in the diabetes-dysregulated proinflammatory response. Supportively, apoptotic cell clearance, which is an important function of macrophages, appeared to be impaired in the diabetic group, with a significantly increased protein level of CALR (calreticulin), an "eat-me" signal on the surface of apoptotic cells (P=.031), along with an increase of AXL (AXL receptor tyrosine kinase) (P=.030), which mediates apoptotic cell clearance. CONCLUSION: Diabetes was associated with altered long-term inflammatory response in complicated mesh implantation, particularly involving innate immune cell dysfunction. Suboptimal blood glycemic control following mesh implantation may contribute to this immune dysregulation, necessitating further mechanistic studies.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Liang R, Shaker ER, Zhao M, et al. Dysregulated inflammatory response to urogynecologic meshes in women with diabetes and its implications. Am J Obstet Gynecol. 2024. PMID: 38408622. doi:10.1016/j.ajog.2024.02.282

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。